Page 51 - Vitamin D and Cancer
P. 51

38                                            J. Thorne and M.J. Campbell

            vitamin D up-regulated protein 1, which binds to the disulfide reducing protein
            thioredoxin and inhibits its ability to neutralize ROS, thereby potentiating stress-
            induced apoptosis [162, 163]. In other cells, the apoptotic response is delayed and
            not so pronounced, and probably reflecting less direct effects. Taken together, these
            data suggest that extent and timing of apoptotic events depend on the integration of
            VDR  actions  with  other  cell  signaling  systems.  This  regulation  of  apoptosis  in
            human cancer cell lines reflects, of course, the absence of apoptosis in chondro-
            cytes in the Vdr -/- animals [7].



            2.4   Mechanisms of Resistance Toward the VDR


            A major limitation in the therapeutic exploitation of VDR in cancer therapies is the
            resistance of cancer cells toward 1a,25(OH) D . An understanding of the molecular
                                                 3
                                               2
            mechanisms of resistance has emerged.


            2.4.1   Reduced Local Availability of 1a,25(OH) D
                                                            2  3

            Tumors, such as breast cancer appear to distort the VDR signaling axis locally,
            with  reduced  CYP27b1  mRNA  and  protein  levels,  and  comparative  genome
            hybridization studies have found that CYP24 is amplified in human breast cancer
            [164, 165]. Thus, cancer cells maybe associated with low circulating concentrations
            of 25(OH)D , arising as a result of reduced exposure to sunlight, altered dietary
                      3
            patterns, and exacerbated further by impaired local generation of 1a,25(OH) D .
                                                                             3
                                                                           2
            In support of these in vitro findings, a large number of epidemiological studies have
            identified an association between environments of reduced serum 25(OH)D and
            cancer rates.


            2.4.2   Dominant Signal Transduction Events


            In terms of distribution, evidence is emerging that the normally dynamic flux of the
            VDR becomes altered in more transformed and aggressive cancer cells, becoming
            restricted  to  the  nucleus  [166,  167].  These  findings  that  the  normal  transport
            rates,  such  as  importin-mediated  processes,  become  distorted  in  malignancy
            and  may  result  in  a  reduced  ability  for  the  VDR  to  sample  the  cytoplasm  for
            1a,25(OH) D .
                     2
                       3
              Reflecting the cooperative and integrated nature of the VDR to function as a
            transcription factor, a number of workers have identified mechanisms by which
            more  dominant  signaling  process  are  able  either  to  ablate  or  attenuate  VDR
   46   47   48   49   50   51   52   53   54   55   56